Outbreak of Poliomyelitis in Hispaniola Associated with Circulating Type 1 Vaccine-Derived Poliovirus

@article{Kew2002OutbreakOP,
  title={Outbreak of Poliomyelitis in Hispaniola Associated with Circulating Type 1 Vaccine-Derived Poliovirus},
  author={Olen Kew and Victoria Morris-Glasgow and Mauricio Ram{\'i}rez Landaverde and Cara C. Burns and Jing Shaw and Zacar{\'i}as Garib and Jean Andr{\'e} and Elizabeth Blackman and Christopher J Freeman and Jaume Jorba and R. W. Sutter and Gina Tambini and Linda V. Venczel and Cristina Pedreira and Fernando Laender and Hiro Shimizu and Tetsuo Yoneyama and Tatsuo Miyamura and Harrie van der Avoort and M. Steven Oberste and David R. Kilpatrick and Stephen L. Cochi and Mark A Pallansch and Ciro A. de Quadros},
  journal={Science},
  year={2002},
  volume={296},
  pages={356 - 359}
}
An outbreak of paralytic poliomyelitis occurred in the Dominican Republic (13 confirmed cases) and Haiti (8 confirmed cases, including 2 fatal cases) during 2000–2001. All but one of the patients were either unvaccinated or incompletely vaccinated children, and cases occurred in communities with very low (7 to 40%) rates of coverage with oral poliovirus vaccine (OPV). The outbreak was associated with the circulation of a derivative of the type 1 OPV strain, probably originating from a single… Expand
Paralytic poliomyelitis caused by a vaccine-derived polio virus in an antibody-deficient Argentinean child.
TLDR
A 3-year-old Argentinean boy with X-linked hypogammaglobulinemia is described, the first case reported of a vaccine-derived poliovirus infection recorded in continental Latin America. Expand
Outbreak of poliomyelitis due to type 3 poliovirus, northern India, 1999-2000: injections a major contributing factor.
TLDR
It is confirmed that injections administered during the poliovirus incubation period can provoke paralytic poliomyelitis, and injections in polio-endemic countries should only be indicated when other therapeutic options have failed or are not available. Expand
Circulating Vaccine Derived Poliovirus and the polio eradication endgame
The world is now in the 24th year of the Global Polio Eradication Initiative. Halfway through that initiative in 2000, the island of Hispaniola saw an outbreak of vaccine derived poliovirus. TheExpand
Recombinant Vaccine–Derived Poliovirus in Madagascar
TLDR
Nine type 2 poliovirus (PV) strains were isolated in the southern province of the Republic of Madagascar and the existence of two lineages derived from different recombination events with two nonidentified enteroviruses of the phylogenetic cluster C was confirmed. Expand
Reemergence of recombinant vaccine-derived poliovirus outbreak in Madagascar.
TLDR
The occurrence of an outbreak due to VDPVs 3 years after a previous outbreak indicates that a short period with low vaccination coverage is enough to create favorable conditions for the emergence of VDPV in this setting. Expand
Polio vaccines and the eradication of poliomyelitis
TLDR
A case-control analysis of vaccination history data from children in Pakistan and Afghanistan is described, in which the clinical eff ectiveness of oral monovalent, bivalent, and trivalent poliovirus vaccines (OPVs) is estimated. Expand
Isolation of an Intertypic Poliovirus Capsid Recombinant from a Child with Vaccine-Associated Paralytic Poliomyelitis
TLDR
The isolation of a capsid intertypic poliovirus recombinant from a child with vaccine-associated paralytic poliomyelitis resulted in a poliov virus chimera containing the entire coding sequence for antigenic site 3a derived from the Sabin type 2 strain. Expand
Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitis.
TLDR
This group of patients with vaccine-associated paralytic poliomyelitis appears to be an unlikely source of poliovirus reintroduction in developed countries because of the rarity and high fatality rate of iVAPP and the possible spontaneous clearance ofPolioviruses. Expand
Circulating vaccine-derived polioviruses: current state of
Within the past 4 years, poliomyelitis outbreaks associated with circulating vaccine-derived polioviruses (cVDPVs) have occurred in Hispaniola (2000-01), the Philippines (2001), and MadagascarExpand
Vaccine-associated paralytic poliomyelitis caused by contact infection.
TLDR
An adult patient with acute anterior poliomyelitis (AAP), whose monoparesis developed 28 days after his son's immunization with oral poliovirus vaccine (OPV), raises the question about OPV in polio-free countries. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 18 REFERENCES
Outbreaks of paralytic poliomyelitis, 1976-1995.
TLDR
Findings illustrate the potential for wide dissemination of wild poliovirus infection and underscore the critical need for maintaining high levels of immunity in all countries and for more aggressive vaccination efforts in areas in which polio is endemic. Expand
Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease.
  • P. Strebel, R. Sutter, +6 authors A. Hinman
  • Medicine
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 1992
TLDR
It is suggested that adoption of a sequential vaccination schedule (inactivated poliovirus vaccine followed by OPV) would be effective in decreasing the risk of VAPP while retaining the proven public health benefits of OPV. Expand
Resolution of the Pathways of Poliovirus Type 1 Transmission during an Outbreak
TLDR
The combined epidemiologic and molecular data suggest that a single founder strain was introduced into Israel from the vicinity of Gaza in the fall of 1987 and spread north by the following summer into the Hadera subdistrict of Israel, where it radiated via multiple chains of transmission into other communities in northern Israel and the West Bank. Expand
Risk of vaccine-associated paralytic poliomyelitis in Latin America, 1989-91.
TLDR
Analysis of cases of acute flaccid paralysis reported in Latin America over the period 1989-91 suggests that to eradicate poliomyelitis globally, strategies that rely on mass immunization campaigns to supplement routine delivery services, as recommended by WHO, do not appear to alter significantly the risk of VAPP. Expand
The epidemiology of poliomyelitis: enigmas surrounding its appearance, epidemicity, and disappearance.
TLDR
The eradication of poliomyelitis in spite of the fact that no more than 90% of US children have been reached indicates that either vaccine virus has spread to the unimmunized or a herd immunity effect is operating and the resultant disappearance of wild poliovirus prevents exposure of the unim immunized. Expand
Molecular detection of an importation of type 3 wild poliovirus into Canada from The Netherlands in 1993
TLDR
The results of this study show that the utilization of PCR-based diagnostics offers an important molecular tool for the concise and rapid surveillance of possible cases of wild poliovirus importation into communities with individuals at risk for infection. Expand
Molecular Evolution of a Type 1 Wild-Vaccine Poliovirus Recombinant during Widespread Circulation in China
TLDR
It is proposed that the recombinant virus arose during mixed infection of a single individual in northern China in early 1991 and that its progeny spread by multiple independent chains of transmission into some of the most populous areas of China within a year of the initiating infection. Expand
Stopping poliovirus vaccination after eradication: issues and challenges.
TLDR
The current state of knowledge is summarized, an update on the processes and timelines for certification, containment, and stopping vaccination are provided, and some of the unanswered scientific questions that will be addressed by further research are highlighted. Expand
Comparative study of five methods for intratypic differentiation of polioviruses
TLDR
It is recommended that at least two methods be used for the intratypic differentiation of poliovirus isolates, and each method should be based on a different principle (i.e., antigenic properties and nucleotide sequence composition). Expand
Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine
TLDR
Although nucleotide 2741, 3Dpol, and the 3'-noncoding region of P1/Sabin contribute to the temperature sensitivity of P3/Mahoney, they do not contribute to attenuation in transgenic mice expressing the poliovirus receptor, demonstrating that determinants of attenuation and temperature sensitivity can be genetically separated. Expand
...
1
2
...